L. Bartalini
YOU?
Author Swipe
View article: Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine–nab-paclitaxel failure: a propensity score-matched analysis
Second-line 5-FU plus nanoliposomal irinotecan versus FOLFOX/XELOX in metastatic pancreatic cancer after gemcitabine–nab-paclitaxel failure: a propensity score-matched analysis Open
5-FU + Nal-IRI showed a modest yet statistically significant survival advantage compared with FOLFOX/XELOX in patients with metastatic PDAC previously treated with GemNab, despite being associated with a higher incidence of adverse events.…
View article: Negative impact of corticosteroid use on outcome in patients with advanced <scp>BTCs</scp> treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population
Negative impact of corticosteroid use on outcome in patients with advanced <span>BTCs</span> treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population Open
In recent years, there has been increasing interest in the possible prognostic impact of concomitant medications in patients with cancer treated with immunotherapy combinations. This real‐world analysis aims to evaluate the impact of conco…
View article: Sustained Partial Response Of Metastatic Castration-Resistant Prostate Cancer With Bilobar Hepatic Involvement Treated With Intra-Arterial Hepatic Chemotherapy: A Case Report
Sustained Partial Response Of Metastatic Castration-Resistant Prostate Cancer With Bilobar Hepatic Involvement Treated With Intra-Arterial Hepatic Chemotherapy: A Case Report Open
Metastatic castration-resistant prostate cancer (mCRPC) with liver metastases often has poor outcomes with conventional therapies showing limited effectiveness. This case report describes a 59-year-old man with mCRPC and extensive liver me…
View article: Network meta‐analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence
Network meta‐analysis of adjuvant chemotherapy in biliary tract cancers: Setting the scene for new randomized evidence Open
Background and Aims The best adjuvant chemotherapy for resected biliary tract cancer (BTC) is under debate, with capecitabine supported by weak evidence. Aim of this network meta‐analysis is to estimate the efficacy of different phase II/I…
View article: The technique and evaluation of dynamic shoulder MR imaging in subacromial impingement syndrome
The technique and evaluation of dynamic shoulder MR imaging in subacromial impingement syndrome Open
Poster: ECR 2018 / C-2034 / The technique and evaluation of dynamic shoulder MR imaging in subacromial impingement syndrome by: C. Ojango 1, L. Bartalini2, M. Signorini2, S. Masala1, S. urgelli2, F. S. Ferrari2; 1Rome/IT, 2Siena/IT